Parkes v. NYU Langone Health

CourtDistrict Court, S.D. New York
DecidedJune 9, 2025
Docket1:24-cv-08099
StatusUnknown

This text of Parkes v. NYU Langone Health (Parkes v. NYU Langone Health) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Parkes v. NYU Langone Health, (S.D.N.Y. 2025).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK TIFFANY-ANNE PARKES, Plaintiff, 24-CV-8099 (KMW) -against- NYU LANGONE HEALTH; GRAMERCY ORDER OF DISMISSAL GYNECOLOGY; TEMITOPE AWOSOGBA, WITH LEAVE TO REPLEAD MD, Defendants. KIMBA M. WOOD, United States District Judge: Plaintiff, appearing pro se, brings this action claiming federal question jurisdiction and diversity of citizenship jurisdiction, alleging claims in medical malpractice and negligence. By order dated November 20, 2024, ECF No. 5, the Court granted Plaintiff’s request to proceed in forma pauperis (“IFP”), that is, without prepayment of fees.

STANDARD OF REVIEW The Court must dismiss an IFP complaint, or any portion of the complaint, that is frivolous or malicious, fails to state a claim on which relief may be granted, or seeks monetary relief from a defendant who is immune from such relief. 28 U.S.C. § 1915(e)(2)(B); see Livingston v. Adirondack Beverage Co., 141 F.3d 434, 437 (2d Cir. 1998). The Court must also dismiss a complaint when the Court lacks subject matter jurisdiction over the claims raised. See Fed. R. Civ. P. 12(h)(3). Although the law mandates dismissal on any of these grounds, the Court is obligated to construe pro se pleadings liberally, Harris v. Mills, 572 F.3d 66, 72 (2d Cir. 2009), and to interpret them to raise the “strongest [claims] that they suggest,” Triestman v. Fed. Bureau of Prisons, 470 F.3d 471, 474 (2d Cir. 2006) (per curiam) (internal quotation marks and citations omitted) (emphasis in original). But the “special solicitude” courts provide to pro se litigants, id. at 475 (citation omitted), has its limits—to state a claim, pro se pleadings still must comply with Rule 8 of the Federal Rules of Civil Procedure, which requires a complaint to make a short and

plain statement showing that the pleader is entitled to relief. Fed. R. Civ. P. 8(a)(2). Rule 8 requires a complaint to include enough facts to state a claim for relief “that is plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). A claim is facially plausible if the plaintiff pleads enough factual detail to allow the Court to draw the inference that the defendant is liable for the alleged misconduct. Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). In reviewing the complaint, the Court must accept all well-pleaded factual allegations as true, but it need not accept as true “[t]hreadbare recitals of the elements of a cause of action, supported by mere conclusory statements.” Id. at 678-79. After separating legal conclusions from well- pleaded factual allegations, the Court must determine whether those facts make it plausible—not merely possible—that the pleader is entitled to relief. Id.

BACKGROUND The following facts are drawn from the complaint naming as Defendants NYU Langone Health (“NYU”), Gramercy Gynecology, and Dr. Temitope Awosogba.1 In August of 2020, Plaintiff went to see Dr. Awosogba at Gramercy Gynecology “for an annual exam/pap smear as well as to look into a large mass that had been protruding from [Plaintiff’s] lower, right abdomen.” (ECF 1 at 2.) Dr. Awosogba told Plaintiff that a subsequent magnetic resonance imaging (“MRI”) test showed “a total of twelve fibroids” in Plaintiff’s uterus, although Plaintiff

1 The Court quotes from the complaint verbatim. All spelling, grammar, and punctuation are as in the original unless noted otherwise. never saw the MRI results herself. (Id.) On the advice of Dr. Awosogba, Plaintiff had fibroid removal surgery on October 28, 2020 which “lasted much longer than [Plaintiff] was told to expect.” (Id.) Plaintiff had multiple problems after the surgery, including issues with the “sutures/stitches”; scarring; “significant changes in” her menstrual cycles and bodily functions;

vomiting; abdominal pain; cramping; and sciatic pain. (Id. at 3.) Plaintiff also believes that the surgery will hinder any future attempts on her part to get pregnant and bear a child. (Id. at 4.) Plaintiff sought medical care from other providers and, in 2023, doctors at John Hopkins performed an ultrasound of Plaintiff’s uterus. (Id.) The ultrasound revealed internal scarring that did not exist before the surgery, which Plaintiff claims shows that Dr. Awosogba lied to her, misled her, was negligent, and committed medical malpractice. (Id.) Plaintiff further asserts facts suggesting that NYU falsified its medical records to cover up its culpability. (Id.) Plaintiff seeks $616 million in damages for her physical symptoms, anxiety, and trauma. (Id. at 4.) This matter was initially assigned to Chief Judge Laura Taylor Swain. On May 5, 2025, Plaintiff moved to have this matter reassigned. (ECF 7.) On June 5, 2025, the matter was

reassigned to my docket. DISCUSSION A. Federal question jurisdiction To invoke federal question jurisdiction, a plaintiff’s claims must arise “under the Constitution, laws, or treaties of the United States.” 28 U.S.C. § 1331. A case arises under federal law if the complaint “establishes either that federal law creates the cause of action or that the plaintiff’s right to relief necessarily depends on resolution of a substantial question of federal law.” Bay Shore Union Free Sch. Dist. v. Kain, 485 F.3d 730, 734-35 (2d Cir. 2007) (quoting Empire Healthchoice Assur., Inc. v. McVeigh, 547 U.S. 677, 690 (2006)). The complaint fails to set forth facts suggesting that Plaintiff can state a claim falling under the Court’s federal question jurisdiction. Plaintiff invokes 22 U.S.C. § 2702, but that statute pertains only “to actions for malpractice of physicians who work for the Department of State or any other federal department, agency or instrumentality.” See Blades v. DeJoseph, No.

20-CV-3239, 2020 WL 1902427, at *2 (D.N.J. Apr. 17, 2020) (quoting Thomas v. Griffin Mem’l Hosp., 9 F.3d 1557 (10th Cir. 1993)). Plaintiff does not allege that any Defendant named in this action works for the Department of State or any other federal department, agency or instrumentality. Plaintiff also invokes 21 C.F.R. § 50.25, a regulation that applies “to clinical trials regulated by the Food and Drug Administration.” See Behm v. Mehaljevic, No. 23-CV-2004, 2024 WL 916478, at *2 (N.D. Ohio, Mar. 4, 2024) (“Even liberally construed, the facts in this case do not suggest Plaintiff was part of an FDA [Food and Drug Administration]-regulated clinical drug trial.”) Plaintiff does not allege in her complaint that she was part of an FDA clinical drug trial.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Parkes v. NYU Langone Health, Counsel Stack Legal Research, https://law.counselstack.com/opinion/parkes-v-nyu-langone-health-nysd-2025.